William Campbell

Nessuna posizione attualmente

82 anni

Consumer Services

Health Technology

Technology Services

Profilo

William Campbell served as Chairman at Kinexus Bioinformatics Corp.
and as Director & Chief Scientific Officer at Regenerex Pharma, Inc. He received his undergraduate degree from Concordia University in 1962 and his doctorate degree from the University of Montréal in 1971.

Precedenti posizioni note di William Campbell

Società	Posizione	Fine
Kinexus Bioinformatics Corp. Kinexus Bioinformatics Corp. Packaged SoftwareTechnology Services Kinexus Bioinformatics Corp. provides specialized proteomics services for tracking protein kinases and other cell signaling proteins. The firm maps and monitors the molecular communications networks of living cells for biomedical research into the diagnosis, prognosis and treatment of human diseases. The firm offers cell culture, kinase-substrate profiling, kinase-inhibitor profiling, mass spectrometry, protein & peptide production, custom graphics, technical support and data security services. The company was founded by Steven Pelech on July 30, 1999 and is headquartered in Vancouver, Canada.	Presidente	-
PEPTIDE TECHNOLOGIES INC	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di William Campbell

Formazione di William Campbell

Concordia University	Undergraduate Degree
University of Montréal	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di William Campbell

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
PEPTIDE TECHNOLOGIES INC	Health Technology

Aziende private	1
Kinexus Bioinformatics Corp. Kinexus Bioinformatics Corp. Packaged SoftwareTechnology Services Kinexus Bioinformatics Corp. provides specialized proteomics services for tracking protein kinases and other cell signaling proteins. The firm maps and monitors the molecular communications networks of living cells for biomedical research into the diagnosis, prognosis and treatment of human diseases. The firm offers cell culture, kinase-substrate profiling, kinase-inhibitor profiling, mass spectrometry, protein & peptide production, custom graphics, technical support and data security services. The company was founded by Steven Pelech on July 30, 1999 and is headquartered in Vancouver, Canada.	Technology Services